Services for Citizens | Pharmacovigilance | CINFA International

Pharmacovigilance
 

Services for Citizens

Laboratorios Cinfa has a Pharmacovigilance System for the collection and analysis of any suspicion of adverse reactions to the use of its commercialized drugs.

Should you like to notify a suspicion of an adverse reaction to any of our products, please proceed to fill out and send the following form.

* Mandatory fields

Notifying person

Patient identification

Prescribing physician

Should de notifying person be a patient, he gives his consent to Laboratorios CINFA to contacting his physician in order to confidentially fill in additional information related to his case

Suspicious drugs

Other drugs

Adverse Reaction

(*) Seriousness

D: Death | T: Threatens life | H: Hospitalization or extends the length of hospitalization | D: Disability | CR: Clinically relevant | O: Overdose | C: Cancer

(**) Outcome

1: Recovered | 2: Not recovered | 3: Recovering | 4: Recovering with consequences | 5: Fatal

(***) Causality (relationship)

1: Definitely Yes | 2: Probably Yes | 3: Possibly Yes | 4: Possibly No | 5: 5: Probably No | 6: Definitely No | 7: To be determined

Comments

Please send this form even though you may not have all the information.

In accordance to the Data Protection Act 15/1999 established on December 13, LABORATORIOS CINFA, S.A. is committed to ensuring complian- ce with the protection, confidentiality and privacy of personal data and security procedures related to the storage of information regarding the notified adverse reaction, and will take any necessary action to prevent its alteration, loss, unauthorized handling or access. Provided information will be added to the “Pharmacovigilance” file with the only purpose of pharmacovigilance control of the CINFA products. Users shall at all times be able to exercise their rights of access, rectification, cancellation and opposition, according to the terms described at Ley Orgánica 15/1999, with regard to personal data provided communicating by means of written document addressed to our registered offices at Polígono Areta, CP 31620 Huarte-Pamplona, Navarra, Spain, or to our e-mail address farmacovigilancia@cinfa.com, to the attention of the Safety Manager.

Please wait...